The research is documented in a study entitled “Tailoring nanostructure and bioactivity of 3D-printable hydrogels with self-assemble peptides amphiphile (PA) for promoting bile duct formation,” which you can access here. Lead author Ming Yan and colleagues 3D printed a nanostructure consisting of peptides amphiphile, or PAs, bioink and bile duct cells, or cholangiocytes.
“3D-printing has expanded our ability to produce reproducible and more complex scaffold architectures for tissue engineering applications,” the abstract states. “In order to enhance the biological response within these 3D-printed scaffolds incorporating nanostructural features and/or specific biological signaling may be an effective means to optimize tissue regeneration. Peptides amphiphiles (PAs) are a versatile supramolecular biomaterial with tailorable nanostructural and biochemical features. PAs are widely used in tissue engineering applications such as angiogenesis, neurogenesis, and bone regeneration. Thus, the addition of PAs is a potential solution that can greatly expand the utility of 3D bioprinting hydrogels in the field of regenerative medicine.”
The PAs and cholangiocytes were mixed with thiolated gelatin at 37°C and 3D printed at 4ºC using an EnvisionTEC 3D-Bioplotter, one of the most-utilized bioprinters on the market. The material retained integrity as the bioinks printed into filaments capable of supporting multi-layered scaffolds. The researchers stabilized the scaffold by cross-linking a derivative of ethylene glycol with calcium ions; scaffold stability was observed in culture for more than a month at a temperature of 37°C.The researchers also explored the use of a laminin-derived peptide (Ile-Lys-Val-Ala-Val, IKVAV) and the influence its inclusion in the bioink would have on the bile duct cells. Laminin is a molecule necessary for cell adhesion, and after bioprinting, the bile duct cells remained viable in vitro. Staining revealed the formation of functional bile-cell-based tube structures; when cultured in IKVAV bioink, the structures showed enhanced morphology, forming functional tubular structures.
This is the first time that a bioink-based system supplemented with PAs was used for bile duct tissue engineering. The research shows a lot of promise; the bioprinted bile ducts as well as in vitro systems created with the bioinks have the potential to be valuable for research into bile duct cancer as well as the testing of treatments. Right now, bile duct cancer is a grave diagnosis to receive, but the enhanced research that could be made possible by this work offers hope for better understanding and more effective treatments.
As a next step, the researchers now want to optimize the peptide concentration and test other signaling molecules within the bioinks to enhance the formation of functional tubular structures that mimic those found in the liver.
Additional authors of the research paper include P.L. Lewis and R.N. Shah.[Source: Physics World]
You May Also Like
Mitsubishi Electric and AMT Partner for 3D Printing Post-Processing Automation
As discussed in the “Automation, Additive Manufacturing and the Factory of the Future” report from SmarTech Analysis, we’re seeing the 3D printing industry both used as a means of establishing...
3D Printing Webinar and Virtual Event Roundup: April 4, 2021
ASTM’s certificate course continues this week, and Cellink is discussing oncology drug screening applications in a webinar. Those are just two of the topics in this week’s webinar roundup, followed...
Dream 3D Printing Mergers & Acquisitions: What if Henkel Acquired…
Inspired in part by the SPAC mergers of VELO3D with Jaws, Markforged with one, and Rocket Lab with Vector Acquisition Corporation, as well as the acquisition of EnvisionTEC by Desktop Metal, and...
L’Oréal Uses AMFG’s MES Software to Streamline 3D Printing
Personal care and beauty brand L’Oréal has used 3D printing many times in the last several years, for applications ranging from product design to bioprinting hair and skin. The company,...
View our broad assortment of in house and third party products.